Notably, the authors showed that proliferating CD8(+)TCF1(+) T cells were often in contact with cancer cells expressing major histocompatibility complex II, thereby stressing the importance of evaluating cancer–immune interactions [31]. The gene discussed is CD8A; the disease is cancer.